Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.
Ryan A WatsonDrew M JohnsonRobin N DhariaGeno J MerliJohn U DohertyPublished in: Hospital practice (1995) (2020)
Our goal is to provide guidance to the utilization of antithrombotic and antiplatelet therapies in patients with known or suspected COVID-19.